错误部

The Lancet Pub Date : 2025-02-27 DOI:10.1016/s0140-6736(25)00353-8

{"title":"错误部","authors":"","doi":"10.1016/s0140-6736(25)00353-8","DOIUrl":null,"url":null,"abstract":"Baumbach A, van Royen N, Amat-Santos IJ, et al. LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial. Lancet 2024; 403: 2695–708—In the appendix for this Article, the spelling of Dario Pellegrini's name in the LANDMARK trial investigators list was incorrect.The appendix of this Article has been corrected as of Feb 27, 2025.","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"30 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Department of Error\",\"authors\":\"\",\"doi\":\"10.1016/s0140-6736(25)00353-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Baumbach A, van Royen N, Amat-Santos IJ, et al. LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial. Lancet 2024; 403: 2695–708—In the appendix for this Article, the spelling of Dario Pellegrini's name in the LANDMARK trial investigators list was incorrect.The appendix of this Article has been corrected as of Feb 27, 2025.\",\"PeriodicalId\":22898,\"journal\":{\"name\":\"The Lancet\",\"volume\":\"30 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-02-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s0140-6736(25)00353-8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s0140-6736(25)00353-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

王晓明，王晓明，王晓明，等。新一代Myval经导管心脏瓣膜系列与当代瓣膜（Sapien和Evolut）在现实世界严重症状性原生主动脉狭窄患者中的早期结局的里程碑式比较：一项随机非效性试验。《柳叶刀》2024年;403: 2695 - 708在这篇文章的附录中，Dario Pellegrini的名字在LANDMARK试验调查员名单中的拼写是错误的。本文附录已于2025年2月27日更正。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Department of Error

Baumbach A, van Royen N, Amat-Santos IJ, et al. LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial. Lancet 2024; 403: 2695–708—In the appendix for this Article, the spelling of Dario Pellegrini's name in the LANDMARK trial investigators list was incorrect.The appendix of this Article has been corrected as of Feb 27, 2025.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The Lancet

自引率

0.00%

发文量